Last reviewed · How we verify
NCT06000735
Daily Blood Glucose Trends in Patients at Risk for Diabetes
NA trial testing 7-Day Continuous Glucose Monitoring with Abbott Freestyle Libre 2 in Stress in 20 participants. Status unknown.
30 October 2024
Quick facts
| Lead sponsor | Karol E. Watson, MD |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 20 |
| Start date | 1 October 2023 |
| Primary completion | 30 October 2024 |
| Estimated completion | 30 October 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- 7-Day Continuous Glucose Monitoring with Abbott Freestyle Libre 2
Conditions studied
- Stress — all drugs for Stress →
- Blood Sugar; High — all drugs for Blood Sugar; High →
- Cholesterol, Elevated — all drugs for Cholesterol, Elevated →
- Diet Habit — all drugs for Diet Habit →
Sponsor
Karol E. Watson, MD
Who can join
18 and older, any sex, with Stress or Blood Sugar; High. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to learn about the relationship between blood sugar, diet, stress, and metabolic parameters including waist circumference, body mass index (BMI), cholesterol levels and blood pressure in patients at risk for diabetes. The main questions it aims to answer are 1) are there trends in blood sugar responses after meals for patients at risk of developing diabetes? And 2) are there correlations between stress and fluctuations in blood sugar? During the first visit, participant's waist circumference, body composition, cholesterol, and resting blood pressure will be measured, and a continuous glucose monitor sensor will be placed on the participant's non-dominant arm. This sensor will be worn for seven days, and the participant will be asked to complete a daily food log during that time. Each participant will be asked to return to clinic after one week to return the continuous glucose monitor and daily food log.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06000735
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stress
Currently open trials in the same condition.
- NCT07485790 — The Effects of Yoga on Pregnant Women · NA · recruiting
- NCT07469527 — Effects of Feel Free® Classic Tonic on Stress and Pharmacokinetics in Healthy Adults · NA · recruiting
- NCT07387107 — Decreasing Stress Via Virtual Reality and Binaural Beats in Non-Clinical Adults · NA · recruiting
- NCT07240792 — Development of a College Student-Delivered Cognitive-Behavioral Therapy (CBT) Intervention for Rural High School Student · NA · recruiting
- NCT07518056 — Relationships Between Nomophobia Levels and Perceived Stress, Body Image and Food Addiction Among University Students · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06000735 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karol E. Watson, MD
- Last refreshed: 21 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06000735.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing